Nisha Ravindran

Assistant Professor

University of Toronto

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Nisha Ravindran is an Assistant Professor at the University of Toronto in Canada. Her research focuses on treatment-resistant depression, including the efficacy of esketamine and novel therapies in clinical practice. She has contributed to guidelines on managing major depressive disorder and has explored various treatment methodologies for mood disorders in both high and low-middle income countries.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (10)

Daniel Mueller

Full Professor

University of Toronto

CANADA

View details

Lakshmi N Yatham

Professor and Head

The University of British Columbia

CANADA

University of Alberta

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nisha Ravindran

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Abuse liability for esketamine in a cohort of patients undergoing an acute treatment course to manage treatment-resistant depression: a secondary analysis of an observational study in real-world clinical practicee

IN Esketamine and IV Ketamine: Results of a multi-site observational study assessing the effectiveness and tolerability of two novel therapies for treatment-resistant depression

Evaluating the use of electroconvulsive therapy in low-middle income countries: A narrative review

Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression

Acceptability of A Web-based Character Strengths Module for Early Adolescent School Children

Characteristics of psychomotor retardation distinguishes patients with depression using multichannel near-infrared spectroscopy and finger tapping task

Association of intranasal esketamine, a novel ‘standard of care’ treatment and outcomes in the management of patients with treatment-resistant depression: protocol of a prospective cohort observational study of naturalistic clinical practice

Randomized, Placebo-Controlled Effectiveness Study of Quetiapine XR in Comorbid Depressive and Anxiety Disorders.

Treatments for child and adolescent attention deficit hyperactivity disorder in low and middle-income countries: A narrative review

Differentiating between bipolar and unipolar depression using prefrontal activation patterns: Promising results from functional near infrared spectroscopy (fNIRS) findings

Prevalence and correlates of suicidal ideation among the general population in China during the COVID-19 pandemic

Party drug to mainstream medicine; the transition of ketamine

Collaborators (10)

Daniel Mueller

Lakshmi N Yatham

Gustavo Vazquez

Sean Nestor

Peter Giacobbe

Raymond W. Lam

G. Camelia Adams

Zainab Samaan

Samuel Law

Swainson Jennifer

Make your next move.